News | January 03, 2024
Glenmark to launch biosimilar of anti-diabetic drug Liraglutide in India
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
Subscribe To Our Newsletter & Stay Updated
